Simpson P J, Lucchesi B R
J Lab Clin Med. 1987 Jul;110(1):13-30.
There is a growing body of evidence for the role of free radicals in mediating myocardial tissue injury during myocardial ischemia and in particular during the phase of myocardial reoxygenation. Associated with myocardial ischemia and reperfusion is the generation of oxygen-derived free radicals from a variety of sources that include the mitochondrial electron transport chain; the biosynthesis of prostaglandins; the enzyme xanthine oxidase; and circulating elements in the blood, with the polymorphonuclear neutrophil assuming a primary focus of attention. Experimental studies have shown that free radical scavengers (e.g., N-[2-mercaptopropionyl]glycine) and enzymes that scavenge or degrade reactive species of oxygen (superoxide dismutase or catalase) can reduce the mass of myocardial tissue that undergoes irreversible injury. Additionally allopurinol, which inhibits the enzyme xanthine oxidase, reduces ultimate infarct size, putatively by reducing the xanthine oxidase generation of superoxide anion. Neutrophils that enter the ischemically injured myocardium under the influence of chemotactic attraction and activation of the complement system generate and release highly reactive and cytotoxic oxygen derivatives that are destructive to the vascular endothelium and to the cardiac myocytes. Studies have documented that neutrophil depletion or suppression of neutrophil function (ibuprofen, nafazatrom, BW 755C, or more recently with prostacyclin or iloprost) results in a significant salvage of myocardial tissue that is subjected to a period of regional ischemia followed by reperfusion. Our current understanding of the events associated with myocardial ischemia suggests that within the ischemic myocardial region or area at risk, there is a population of cells that are reversibly injured and that reperfusion within a specified period (less than 3 hours) of time is capable of restoring the majority of the jeopardized cells to a normal status, but that the act of reperfusion itself will lead to the sudden demise of a fraction of the cells because of the cytotoxic effects of reactive species of oxygen derived from one or more of the sources indicated above. The efforts to minimize the amount of tissue that undergoes cell death as a result of myocardial ischemia demand that early reperfusion be established. However, the reintroduction of molecular oxygen and the circulating elements of the blood will be associated with an "explosive" and self-limited destruction of some of the myocardial cells in the area at risk.(ABSTRACT TRUNCATED AT 400 WORDS)
越来越多的证据表明,自由基在介导心肌缺血期间尤其是心肌再灌注阶段的心肌组织损伤中发挥作用。与心肌缺血和再灌注相关的是,多种来源会产生氧衍生自由基,这些来源包括线粒体电子传递链、前列腺素的生物合成、黄嘌呤氧化酶以及血液中的循环成分,其中多形核中性粒细胞成为主要关注焦点。实验研究表明,自由基清除剂(如N-[2-巯基丙酰基]甘氨酸)以及清除或降解活性氧物种的酶(超氧化物歧化酶或过氧化氢酶)能够减少发生不可逆损伤的心肌组织量。此外,抑制黄嘌呤氧化酶的别嘌呤醇可减小最终梗死面积,推测是通过减少黄嘌呤氧化酶产生超氧阴离子来实现的。在趋化吸引和补体系统激活的影响下进入缺血损伤心肌的中性粒细胞会产生并释放高反应性和细胞毒性的氧衍生物,这些衍生物会对血管内皮和心肌细胞造成破坏。研究记录表明,中性粒细胞减少或中性粒细胞功能抑制(布洛芬、萘呋胺酯、BW 755C,或者最近使用前列环素或伊洛前列素)会显著挽救经历一段时间局部缺血后再灌注的心肌组织。我们目前对与心肌缺血相关事件的理解表明,在缺血心肌区域或危险区域内,存在一群可逆性损伤的细胞,在特定时间段(少于3小时)内进行再灌注能够使大多数处于危险中的细胞恢复到正常状态,但再灌注本身的行为会由于上述一种或多种来源产生的活性氧物种的细胞毒性作用导致一部分细胞突然死亡。为尽量减少因心肌缺血导致细胞死亡的组织量,需要尽早建立再灌注。然而,分子氧和血液中循环成分的重新引入将与危险区域内一些心肌细胞的“爆发性”且自我限制的破坏相关。(摘要截断于400字)